Chevallier, P., Labopin, M., Socié, G., Tabrizi, R., Furst, S., Lioure, B., Guillaume, T., Delaunay, J., de La Tour, R. P., Vigouroux, S., El-Cheikh, J., Blaise, D., Michallet, M., Bilger, K., Milpied, N., Moreau, P. and Mohty, M. (2014) “Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial”, Haematologica. Pavia, Italy, 99(9), pp. 1486-1491. doi: 10.3324/haematol.2014.108563.